Artefill® is the first and only microsphere-enhanced collagen filler for the correction of nasolabial folds, or the lines from your nose to the corners of your mouth.
If you've used temporary dermal fillers in the past, then you know they are eventually absorbed by your body and require frequent repeat injections to maintain the results you've come to love.
Artefill® is different. The unique microspheres contained within Artefill® are not absorbed by the body, providing the support structure your skin needs for smooth, natural results. If you are looking for a long-lasting filler that you can have confidence in, then Artefill® may be right for you.
Artefill® consists of a combination of microsphere enhanced collagen and lidocaine for comfort.
Artefill® is a dual-acting wrinkle filler. Once it’s injected into the deep portion of the skin under the wrinkle, the collagen in Artefill® visibly corrects the wrinkle. Over time the collagen is absorbed by the body but the microspheres remain intact providing the support your skin needs for long-lasting, natural feeling wrinkle correction.
This safe, in-office procedure takes a just a few minutes to administer. You will receive an anesthetic to lessen the pain from the procedure and with proper placement you won’t feel a thing and can return to your normal daily activities. The results are immediate and will improve over time.
If you love the wrinkle correction you get from temporary fillers but are tired of retuning for repeat treatments, then Artefill® may be the ideal solution for you.
Artefill® is the only soft tissue filler product on the market designed to last. Thousands of patients in the U.S. have been successfully treated with Artefill® and those numbers continue to increase. Artefill® is also one of the only products to report a patient satisfaction rating over 90% during its pivotal clinical trial. Listen to what some actual patients had to say about their experience with Artefill®.
Yes. Artefill® has proven to be a safe and effective dermal filler for the correction of wrinkles and was approved by the U.S. FDA in October 2006. In clinical testing, Artefill® was as safe as the control temporary filler.
Since the launch of Artefill® in 2007, thousands of patients have been safely treated with Artefill® and there have been no product recalls and no reported medical device events.
Temporary dermal fillers are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and as a result, wrinkle correction usually lasts for only 3-9 months.
The microsphere enhanced collagen in Artefill® remains intact at the treatment site and provides structural support to keep your wrinkle from returning.
No. Some people are not good candidates for Artefill®.
Artefill® is contraindicated in those who:
Yes. If you have any skin outbreaks (e.g. cysts, pimples, rashes, hives, infection) near the injection site, you should postpone treatment until they clear. If you are taking aspirin (NSAIDs) or anti-inflammatory drugs or have any medical condition that affects your blood, you may experience increased bruising or bleeding at the injection sites.
In addition, you should inform us if:
Yes, you should know:
As with any injectable wrinkle filler, you can expect mild swelling and reddening at the treatment site. These side effects are usually gone within 24 hours. Occasionally, there is mild bruising that typically disappears in three to seven days. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, and increased sensitivity at some or all injection sites. Two other rare potential side effects of all dermal fillers may be lumps and granulomas, both of which can be treated by your physician.
You will see results immediately. In the U.S. clinical study, full wrinkle correction was maintained for up to one year.
Most people get the results they want with one or two treatments, depending on the depth of their wrinkles and folds. When you have your follow-up appointment in four to six weeks, you can decide if you would like to further enhance your results.
With proper placement, Artefill® may not be felt after treatment. You will see the results immediately and be able to return to your normal daily activities.
Studies have shown that patients injected with microsphere-enhanced collagen, still reflect a natural appearance in both their overall facial appearance as well as in the area treated 5 years from their initial treatment. These patients were surveyed and had a 90% satisfaction rating related to their wrinkle correction and experience with Artefill®.
The skin test is a safety precaution to ensure that you are not allergic to the collagen or anesthetic in Artefill®.
Several clinical studies were conducted in the United States to demonstrate the safety and effectiveness of the microsphere dermal filler technology. The data from our clinical trials were subject to a full and open review in a public hearing by an FDA review panel. Artefill® was approved by the FDA in October 2006.
A follow-up study of patients from the controlled clinical study were followed over a 5-year period after treatment. Independent expert observers rated photographs of patient wrinkles at five years compared to before treatment and six months after treatment. The physician investigators of this follow-up study concluded that the treatment safely maintains significant correction of smile lines for at least five (5) years post-treatment.
Yes. A post-approval marketing study was initiated in October 2007 to evaluate the long term safety of Artefill®. The study will follow 1,000 patients treated with Artefill® for a period of five years.
To date, thousands of patients in the U.S. have been treated successfully with Artefill®.
Persistent lumps are a rare potential side effect of all dermal fillers, including Artefill®, and can be treated effectively.
Yes, an Artefill® skin test is required prior to treatment to make sure that you are not allergic to the collagen in Artefill®.
Dr. Schlesinger and our staff are members of the following organizations:
